280 related articles for article (PubMed ID: 28536921)
1. Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases.
Gieselbach RJ; Muller-Hansma AH; Wijburg MT; de Bruin-Weller MS; van Oosten BW; Nieuwkamp DJ; Coenjaerts FE; Wattjes MP; Murk JL
J Neurol; 2017 Jun; 264(6):1155-1164. PubMed ID: 28536921
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.
Balak DMW; Hajdarbegovic E; Bramer WM; Neumann HAM; Thio HB
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1475-1482. PubMed ID: 28322482
[TBL] [Abstract][Full Text] [Related]
3. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
4. A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors.
Engel S; Molina Galindo LS; Bittner S; Zipp F; Luessi F
J Cent Nerv Syst Dis; 2021; 13():11795735211037798. PubMed ID: 34992484
[TBL] [Abstract][Full Text] [Related]
5. Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.
Bartsch T; Rempe T; Wrede A; Leypoldt F; Brück W; Adams O; Rohr A; Jansen O; Wüthrich C; Deuschl G; Koralnik IJ
Ann Neurol; 2015 Oct; 78(4):501-14. PubMed ID: 26150206
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy in idiopathic CD4
Aggarwal D; Tom JP; Chatterjee D; Goyal M
Neuropathology; 2019 Dec; 39(6):467-473. PubMed ID: 31584217
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases.
Haider S; Nafziger D; Gutierrez JA; Brar I; Mateo N; Fogle J
Clin Infect Dis; 2000 Oct; 31(4):E20-2. PubMed ID: 11049808
[TBL] [Abstract][Full Text] [Related]
8. Fumaric acid esters for psoriasis: a systematic review.
Smith D
Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
Boster AL; Nicholas JA; Topalli I; Kisanuki YY; Pei W; Morgan-Followell B; Kirsch CF; Racke MK; Pitt D
JAMA Neurol; 2013 Mar; 70(3):398-402. PubMed ID: 23338729
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine.
Nambirajan A; Suri V; Kataria V; Sharma MC; Goyal V
Neurol India; 2017; 65(5):1061-1064. PubMed ID: 28879898
[TBL] [Abstract][Full Text] [Related]
12. Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters.
Sondermann W; Rompoti N; Leister L; Huptas L; Klode J; Dissemond J; Körber A
Dermatology; 2017; 233(4):295-302. PubMed ID: 28954274
[TBL] [Abstract][Full Text] [Related]
13. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
14. Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
Prosperini L; de Rossi N; Scarpazza C; Moiola L; Cosottini M; Gerevini S; Capra R;
PLoS One; 2016; 11(12):e0168376. PubMed ID: 27997580
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia.
Harel A; Horng S; Gustafson T; Ramineni A; Farber RS; Fabian M
J Neurovirol; 2018 Oct; 24(5):652-655. PubMed ID: 29987583
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia.
Delgado-Alvarado M; Sedano MJ; González-Quintanilla V; de Lucas EM; Polo JM; Berciano J
J Neurol Sci; 2013 Apr; 327(1-2):75-9. PubMed ID: 23465508
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy in patients with sarcoidosis.
Jamilloux Y; Néel A; Lecouffe-Desprets M; Fèvre A; Kerever S; Guillon B; Bouvry D; Varron L; Redares C; Dominique S; Roux M; Chapelon-Abric C; Valeyre D; Ducray F; Bernard C; Broussolle C; Hamidou M; Sève P
Neurology; 2014 Apr; 82(15):1307-13. PubMed ID: 24610328
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.
Gheuens S; Pierone G; Peeters P; Koralnik IJ
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):247-54. PubMed ID: 19828476
[TBL] [Abstract][Full Text] [Related]
20. Single-center experience on progressive multifocal leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU).
Yu H; Wu H; R S; Kaur A; Pasham SR; Upadhaya R; Sriwastava S
J Med Virol; 2022 Aug; 94(8):4015-4022. PubMed ID: 35451090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
